These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2858420)

  • 1. Doxepin in the treatment of chronic urticaria.
    Harto A; Sendagorta E; Ledo A
    Dermatologica; 1985; 170(2):90-3. PubMed ID: 2858420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine.
    Demaubeuge J; Tennstedt D; Broux R
    Dermatologica; 1982 Jun; 164(6):386-94. PubMed ID: 6126399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficiency of mequitazine in the treatment of allergic rhinitis and chronic urticaria in children. A bibliographic systematic review].
    Martín JP; Martinez HG; Pérez GL; Manzur JN
    Rev Alerg Mex; 2008; 55(1):3-9. PubMed ID: 18697448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic idiopathic urticaria treatment.
    Negro-Alvarez JM; Miralles-López JC
    Allergol Immunopathol (Madr); 2001; 29(4):129-32. PubMed ID: 11674926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of doxepin in the treatment of chronic idiopathic urticaria.
    Goldsobel AB; Rohr AS; Siegel SC; Spector SL; Katz RM; Rachelefsky GS; Drayton G; Indianer L; Peter JB; Barr RJ
    J Allergy Clin Immunol; 1986 Nov; 78(5 Pt 1):867-73. PubMed ID: 3782654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria.
    Greene SL; Reed CE; Schroeter AL
    J Am Acad Dermatol; 1985 Apr; 12(4):669-75. PubMed ID: 3886724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative trial of an antihistamine, mequitazine, and placebo.
    Laugier P; Orusco M
    Curr Med Res Opin; 1978; 5(5):371-5. PubMed ID: 26517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria.
    Salisbury J; Bor S; Blair C
    Br J Clin Pract; 1987 Aug; 41(8):859-61. PubMed ID: 2896512
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.
    Sabroe RA; Kennedy CT; Archer CB
    Br J Dermatol; 1997 Sep; 137(3):386-90. PubMed ID: 9349334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxepin in the treatment of chronic urticaria.
    Ledo A; Harto A; Sendagorta E
    J Am Acad Dermatol; 1985 Dec; 13(6):1058-9. PubMed ID: 4078098
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of a new antihistamine, mequitazine, and placebos].
    Gervais P; Gervais A; De Beule R; Van der Bijl W
    Acta Allergol; 1975 Nov; 30(5):286-97. PubMed ID: 1959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
    van Joost T; Blog FB; Westerhof W; Jansen FC; Starink TM; den Boer MS; Kuneman JJ; Harvey SG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of the novel antihistamine BW 825C in the treatment of chronic idiopathic urticaria. A placebo-controlled study.
    Gibson JR; Harvey SG; Barth JH; Moss MY; Burke CA
    Dermatologica; 1984; 169(4):179-83. PubMed ID: 6149965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria.
    Morgan M; Cooke A; Rogers L; Adams-Huet B; Khan DA
    J Allergy Clin Immunol Pract; 2014; 2(5):601-6. PubMed ID: 25213055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terfenadine in chronic urticaria: a comparison with clemastine and placebo.
    Fredriksson T; Hersle K; Hjorth N; Mobacken H; Persson T; Salde L; Salo O; Schmidt H; Thomsen K
    Cutis; 1986 Aug; 38(2):128-30. PubMed ID: 2874958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic resolution of chronic urticaria.
    Ostrov MR
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):227-31. PubMed ID: 7552923
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria.
    Leyh F; Harvey SG; Gibson JR; Manna VK
    J Int Med Res; 1989; 17 Suppl 2():22B-24B. PubMed ID: 2569997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxepin in difficult-to-treat chronic urticaria: A retrospective, cross-sectional study from Turkey.
    Özkaya E; Babuna Kobaner G; Yılmaz Z; Kutlay A
    Dermatol Ther; 2019 Jul; 32(4):e12993. PubMed ID: 31175673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
    Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
    Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.